D. Carlei

发表

Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.

E. Proietti, F. Belardelli, G. Greco, 1998, The Journal of clinical investigation.

Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma

P. Marchetti, G. Cappellini, E. Proietti, 2015, Journal of Translational Medicine.

A good manufacturing practice method to ex vivo expand natural killer cells for clinical use.

R. Foà, A. Guarini, M. Napolitano, 2015, Blood transfusion = Trasfusione del sangue.

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma

M. Falchi, P. Monini, R. Bugarini, 2002, Nature Medicine.

Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial

S. Hohaus, A. Tafuri, D. Prosperi, 2019, Clinical Cancer Research.

Treatment of Kaposi's sarcoma—an update

P. Monini, G. Barillari, B. Ensoli, 2002, Anti-cancer drugs.

SarcomaMechanism of Paclitaxel Activity in Kaposi's

A. Cereseto, P. Monini, G. Barillari, 2000 .

Mechanism of Paclitaxel Activity in Kaposi’s Sarcoma1

A. Cereseto, P. Monini, G. Barillari, 2000, The Journal of Immunology.

Type I IFN Protects Permissive Macrophages from Legionella pneumophila Infection through an IFN-γ-Independent Pathway1

E. Proietti, F. Belardelli, G. Schiavoni, 2004, The Journal of Immunology.

Chimeric Antigen Receptor Immunotherapy for Solid Tumors: Choosing the Right Ingredients for the Perfect Recipe

L. Castiello, D. Carlei, E. Aricò, 2022, Cancers.

Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome‐independent block of angiogenesis and matrix metalloproteinases

M. Falchi, P. Monini, R. Bugarini, 2011, International journal of cancer.

A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1)(HXB2) Rev/Env or codon-optimized HIV-1(JR-FL) gp120 generates durable immune responses in mice.

B. Ensoli, P. Leone, D. Carlei, 2006, The Journal of general virology.

Interferon (IFN)-β Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-α: Differential Effects on Tumorigenicity and Host Response

P. Musiani, P. Lollini, F. Belardelli, 1999 .

Interferon (IFN)- b Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN- a Differential Effects on Tumorigenicity and Host Response

P. Musiani, P. Lollini, F. Belardelli, 1999 .

Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma

P. Marchetti, G. Cappellini, E. Proietti, 2015, Journal of Translational Medicine.

Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor.

M Stürzl, A. Cereseto, P. Monini, 2001, Molecular biology of the cell.

Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-α and HSVtk: perspectives for the generation of cancer vaccines

P. Musiani, F. Belardelli, M. Ferrantini, 1997, Gene Therapy.

The use of HAART for biological tumour therapy.

P. Monini, G. Barillari, B. Ensoli, 2006, Journal of HIV therapy.